Retinal Sensitivity in KCNV2-Associated Retinopathy

KCNV2相关视网膜病变中的视网膜敏感性

阅读:2

Abstract

PURPOSE: The purpose of this study was to analyze the retinal sensitivity under photopic, mesopic, and scotopic conditions in a cohort of patients affected with KCNV2-associated retinopathy. METHODS: Cross-sectional evaluation of molecularly confirmed individuals was conducted. Data were obtained prospectively. The main microperimetry parameters analyzed were mean sensitivity (MS) and number of floor effects (noF) in the central macular zone (CMZ; central 6 degrees) and peripheral macular zone (PMZ; 6 to 10 degrees). Interocular symmetry was also assessed. RESULTS: The MS under photopic, mesopic, and scotopic conditions were, respectively, 20.2 (6.3-29.5, ±6.5), 16.2 (3.7-23.1, ±5.3), and 1.3 (0-13.3, ±3.8) in the right eyes, and 21.1 (9.8-28.9, ±6.1), 16.8 (9.6-23.5, ±4.0), and 1.1 (0-12.4, ±3.5) in the left eyes. MS was highly symmetric between eyes (Pearson correlation coefficient) in photopic (r = 0.96, P < 0.0001), mesopic (r = 0.9, P < 0.0001), and scotopic (r = 0.98, P < 0.0001) testing conditions. MS was also highly symmetric (Pearson coefficient) in the photopic CMZ (r = 0.97, P = 0.0001) and PMZ (r = 0.95, P = 0.0002), mesopic CMZ (r = 0.94, P = 0.0003), and PMZ (r = 0.92, P = 0.0009), and scotopic CMZ (r = 0.99, P < 0.0001) and PMZ (r = 0.99, P < 0.0001).The mean noF (± standard deviation [SD]; range) was 4.6 (SD = ±5.3, range = 0-16) in photopic, 5.0 (SD = ±5.4, range = 0-15) in mesopic, and 23.2 (SD = ±8.6, range = 0-28) in scotopic conditions. Subject 01-041 was the only affected individual in which no floor effect was found. Simple linear regression revealed a significant inverse relationship between age and MS, and a direct relationship between age and noF. CONCLUSIONS: KCNV2-associated retinopathy is a largely symmetric disease from a functional perspective. Despite the early decrease in scotopic retinal sensitivity, our data suggests a large window for photoreceptor rescue with novel treatments, such as gene therapy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。